Investigation of the Drug–Drug Interaction Between α-Lipoic Acid and Valproate via Mitochondrial β-oxidation
Authors:
- 18 July 2008
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 25 (11) , 2639-2649
Abstract
To investigate the potential drug–drug interaction (DDI) between lipoic acid (LA) and valproate (VA) via the mitochondrial β-oxidation pathway in rats. In vitro mitochondrial assays were performed to compare the biotransformation of VA to valproyl-CoA (VA-CoA), in the absence and presence of LA. In vitro microsomal and protein binding assays were performed to elucidate their potential DDI at the microsomal metabolism and distribution levels. A pharmacokinetic study was conducted in Lister Hooded rats to ascertain the in vivo DDI between LA and VA. LA was shown to decrease significantly (p < 0.05) the in vitro formation of VA-CoA in a concentration-dependent manner. Our in vitro assay results confirmed that there was minimal interaction between LA and VA in microsomal metabolism and protein binding. Based on the pharmacokinetic data, the absolute bioavailability of VA was determined to be 1.3 in the presence of LA. Our study demonstrated for the first time that there is a potential DDI between LA and VA at the mitochondrial β-oxidation level. While further clinical study is essential, our preliminary finding suggested that medical practitioners need to be prudent when managing epileptic patients who are co-administered with both VA and LA.Keywords
This publication has 27 references indexed in Scilit:
- Lipoic acid as a novel treatment for Alzheimer's disease and related dementiasPharmacology & Therapeutics, 2007
- Modification of the ultrafiltration technique to overcome solubility and non-specific binding challenges associated with the measurement of plasma protein binding of corticosteroidsJournal of Pharmaceutical and Biomedical Analysis, 2006
- Measurement of drug–protein binding by immobilized human serum albumin-HPLC and comparison with ultrafiltrationJournal of Chromatography B, 2006
- Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNature Reviews Cancer, 2006
- High sensitivity determination of valproic acid in mouse plasma using semi‐automated sample preparation and liquid chromatography with tandem mass spectrometric detectionRapid Communications in Mass Spectrometry, 2005
- Irbesartan and Lipoic Acid Improve Endothelial Function and Reduce Markers of Inflammation in the Metabolic SyndromeCirculation, 2005
- Lipoic acid pretreatment attenuates ferric chloride-induced seizures in the ratBrain Research, 2004
- Plasma Kinetics, Metabolism, and Urinary Excretion of Alpha‐Lipoic Acid following Oral Administration in Healthy VolunteersThe Journal of Clinical Pharmacology, 2003
- Effect of Felbamate on Valproic Acid Disposition in Healthy Volunteers: Inhibition of β‐OxidationEpilepsia, 1996
- Interactions involving new antiepileptic drugsPharmacology & Therapeutics, 1995